Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jul;98(29):e16473.
doi: 10.1097/MD.0000000000016473.

Comparative Efficacy and Safety of Traditional Chinese Patent Medicine for Endometriosis: A Bayesian Network Meta-Analysis Protocol

Affiliations
Free PMC article
Meta-Analysis

Comparative Efficacy and Safety of Traditional Chinese Patent Medicine for Endometriosis: A Bayesian Network Meta-Analysis Protocol

Shuangqian Dong et al. Medicine (Baltimore). .
Free PMC article

Erratum in

Abstract

Background: Endometriosis is a common disease of women of childbearing age. In recent years, the incidence of endometriosis has been on the rise. The main clinical manifestations are pelvic pain and infertility. In recent years, traditional Chinese patent medicine (TCMP) has played an important role in the treatment of endometriosis. So far, there is a lack of comparison among all the current common TCPMs for endometriosis. Consequently, it is indispensable to propose a network meta-analysis (NMA) protocol to discuss the strengths and weaknesses of different TCMPs.

Methods: We will comprehensively and systematically retrieve the relevant Chinese and English databases from their inceptions to the May 2019. All randomized controlled trials (RCTs) of TCMPs for Endometriosis will be included. Two researchers will independently screen literature, extract data and assess the risk of bias of included studies. We will conduct pairwise meta-analyses and Bayesian network meta-analyses to assess all the available evidence. Data will be analyzed using STATA and WinBUGS software.

Results: This work will compare and rank the relative efficacy of different TCPMs in the treatment of endometriosis in detail.

Conclusion: The results of this study will provide reliable evidence for the selection of clinical treatment program and guideline development.

Prospero registration number: CRD42019127781.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Zhou WJ, Yang HL, Shao J, et al. Anti-inflammatory cytokines in endometriosis. Cell Mol Life Sci 2019;76:2111–32. - PubMed
    1. Alimi Y, Iwanaga J, Loukas M, et al. The clinical anatomy of endometriosis: a review. Cureus 2018;10:e3361. - PMC - PubMed
    1. Wang Q, Zhao H, Xiang Q, et al. Effect of Yikun Neiyi Wan on the expression of aromatase P450, COX-2, and ER related receptor in endometrial cells in vitro from patients with endometriosis. J Tradit Chin Med 2009;29:296–300. - PubMed
    1. Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014;29:400–12. - PubMed
    1. Dai Y, Li X, Shi J, et al. A review of the risk factors, genetics and treatment of endometriosis in Chinese women: a comparative update. Reprod Health 2018;15:82. - PMC - PubMed
Feedback